Product Code: ETC13162226 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Psoriasis Therapeutics Market was valued at USD 19 Billion in 2024 and is expected to reach USD 29 Billion by 2031, growing at a compound annual growth rate of 5.90% during the forecast period (2025-2031).
The global psoriasis therapeutics market is experiencing steady growth, driven by the increasing prevalence of psoriasis worldwide. The market is characterized by the presence of a wide range of treatment options including topical medications, systemic therapies, and biologic agents. Biologics have gained significant popularity due to their efficacy in treating moderate to severe psoriasis. Factors such as rising healthcare expenditure, growing awareness about psoriasis, and advancements in treatment options are fueling market growth. Geographically, North America and Europe dominate the market due to high healthcare expenditure and favorable reimbursement policies. However, emerging economies in Asia-Pacific and Latin America are expected to witness rapid market growth due to improving healthcare infrastructure and increasing patient population. Overall, the global psoriasis therapeutics market is poised for continued expansion in the coming years.
The Global Psoriasis Therapeutics Market is witnessing a growing demand for biologic drugs due to their effectiveness in treating moderate to severe psoriasis. The market is also benefiting from the increasing prevalence of psoriasis worldwide, driving the development of novel treatment options such as small molecules and targeted therapies. Another key trend is the rising adoption of combination therapies to improve treatment outcomes and patient adherence. Furthermore, the market is experiencing opportunities for growth in emerging economies with improving healthcare infrastructure and expanding patient population. Overall, the Global Psoriasis Therapeutics Market is poised for expansion driven by advancements in treatment options, increasing awareness about the condition, and the growing focus on personalized medicine approaches.
The Global Psoriasis Therapeutics Market faces several challenges, including limited treatment options for severe cases, high costs associated with biologic therapies, and varying efficacy rates among patients. Additionally, access to healthcare services and medications may be restricted in certain regions, leading to disparities in treatment outcomes. Regulatory hurdles and stringent approval processes for new therapies also pose challenges for market growth. Furthermore, the stigma associated with psoriasis can result in underreporting of cases and reluctance among patients to seek treatment, impacting market demand. Overall, addressing these challenges will require collaboration among healthcare providers, pharmaceutical companies, and policymakers to improve access to innovative treatments, reduce costs, and raise awareness about the importance of managing psoriasis effectively.
The Global Psoriasis Therapeutics Market is primarily driven by the increasing prevalence of psoriasis worldwide, growing awareness about the condition among patients and healthcare professionals, and advancements in biologic therapies for more effective treatment options. Additionally, the rising demand for personalized medicine and targeted therapies, coupled with the expanding pipeline of novel drugs for psoriasis, are contributing to market growth. Moreover, the emphasis on early diagnosis and treatment to improve patient outcomes and quality of life is fueling the demand for psoriasis therapeutics. Factors such as the introduction of innovative treatment modalities, favorable reimbursement policies, and initiatives to improve access to healthcare services are also playing a significant role in driving the market for psoriasis therapeutics.
Government policies related to the Global Psoriasis Therapeutics Market vary by country but generally focus on ensuring access to effective treatments, promoting research and development of new therapies, and regulating the marketing and sale of medications. Many governments provide funding for research into psoriasis and offer subsidies or insurance coverage for psoriasis medications to ensure affordability for patients. Regulatory bodies like the FDA in the US and the EMA in Europe oversee the approval and monitoring of psoriasis drugs to ensure safety and efficacy. Additionally, some countries have specific guidelines for the management of psoriasis within their healthcare systems to standardize treatment approaches and improve patient outcomes. Overall, government policies play a crucial role in shaping the landscape of the Global Psoriasis Therapeutics Market by influencing access, innovation, and quality of care for individuals with psoriasis.
The Global Psoriasis Therapeutics Market is expected to witness steady growth in the coming years due to increasing prevalence of psoriasis worldwide. Factors such as growing awareness about the condition, advancements in treatment options, and rising healthcare expenditure are driving market expansion. Biologic drugs are anticipated to remain the dominant segment, offering targeted therapy with fewer side effects. Additionally, the emergence of novel therapies utilizing innovative mechanisms of action, such as small molecules and gene therapy, is likely to further fuel market growth. However, challenges such as high treatment costs and regulatory hurdles may hinder market progress. Overall, the Global Psoriasis Therapeutics Market is projected to continue its upward trajectory, driven by a combination of technological advancements, increasing patient pool, and expanding research and development activities.
In the global psoriasis therapeutics market, North America holds the largest share due to the high prevalence of psoriasis in the region, along with a well-established healthcare infrastructure and increasing adoption of advanced treatment options. Europe follows closely behind, driven by the presence of key market players and rising awareness about psoriasis among the population. In Asia, the market is witnessing significant growth due to the increasing healthcare expenditure, improving access to treatment, and rising prevalence of psoriasis. The Middle East and Africa region is also experiencing growth, propelled by improving healthcare facilities and rising investments in research and development. Latin America is seeing a steady increase in the demand for psoriasis therapeutics, supported by the expanding pharmaceutical industry and growing awareness about the condition among patients.
Global Psoriasis Therapeutics Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Psoriasis Therapeutics Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Psoriasis Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Global Psoriasis Therapeutics Market - Industry Life Cycle |
3.4 Global Psoriasis Therapeutics Market - Porter's Five Forces |
3.5 Global Psoriasis Therapeutics Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Psoriasis Therapeutics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Global Psoriasis Therapeutics Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
4 Global Psoriasis Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Psoriasis Therapeutics Market Trends |
6 Global Psoriasis Therapeutics Market, 2021 - 2031 |
6.1 Global Psoriasis Therapeutics Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Psoriasis Therapeutics Market, Revenues & Volume, By Plaque Psoriasis, 2021 - 2031 |
6.1.3 Global Psoriasis Therapeutics Market, Revenues & Volume, By Psoriatic Arthritis, 2021 - 2031 |
6.2 Global Psoriasis Therapeutics Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Psoriasis Therapeutics Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.2.3 Global Psoriasis Therapeutics Market, Revenues & Volume, By Parenteral, 2021 - 2031 |
6.2.4 Global Psoriasis Therapeutics Market, Revenues & Volume, By Topical, 2021 - 2031 |
6.3.1 Overview & Analysis |
7 North America Psoriasis Therapeutics Market, Overview & Analysis |
7.1 North America Psoriasis Therapeutics Market Revenues & Volume, 2021 - 2031 |
7.2 North America Psoriasis Therapeutics Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Psoriasis Therapeutics Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Psoriasis Therapeutics Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Psoriasis Therapeutics Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Psoriasis Therapeutics Market, Revenues & Volume, By Type, 2021 - 2031 |
7.4 North America Psoriasis Therapeutics Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
8 Latin America (LATAM) Psoriasis Therapeutics Market, Overview & Analysis |
8.1 Latin America (LATAM) Psoriasis Therapeutics Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Psoriasis Therapeutics Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Psoriasis Therapeutics Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Psoriasis Therapeutics Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Psoriasis Therapeutics Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Psoriasis Therapeutics Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Psoriasis Therapeutics Market, Revenues & Volume, By Type, 2021 - 2031 |
8.4 Latin America (LATAM) Psoriasis Therapeutics Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
9 Asia Psoriasis Therapeutics Market, Overview & Analysis |
9.1 Asia Psoriasis Therapeutics Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Psoriasis Therapeutics Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Psoriasis Therapeutics Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Psoriasis Therapeutics Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Psoriasis Therapeutics Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Psoriasis Therapeutics Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Psoriasis Therapeutics Market, Revenues & Volume, By Type, 2021 - 2031 |
9.4 Asia Psoriasis Therapeutics Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
10 Africa Psoriasis Therapeutics Market, Overview & Analysis |
10.1 Africa Psoriasis Therapeutics Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Psoriasis Therapeutics Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Psoriasis Therapeutics Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Psoriasis Therapeutics Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Psoriasis Therapeutics Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Psoriasis Therapeutics Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Psoriasis Therapeutics Market, Revenues & Volume, By Type, 2021 - 2031 |
10.4 Africa Psoriasis Therapeutics Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
11 Europe Psoriasis Therapeutics Market, Overview & Analysis |
11.1 Europe Psoriasis Therapeutics Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Psoriasis Therapeutics Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Psoriasis Therapeutics Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Psoriasis Therapeutics Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Psoriasis Therapeutics Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Psoriasis Therapeutics Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Psoriasis Therapeutics Market, Revenues & Volume, By Type, 2021 - 2031 |
11.4 Europe Psoriasis Therapeutics Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
12 Middle East Psoriasis Therapeutics Market, Overview & Analysis |
12.1 Middle East Psoriasis Therapeutics Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Psoriasis Therapeutics Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Psoriasis Therapeutics Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Psoriasis Therapeutics Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Psoriasis Therapeutics Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Psoriasis Therapeutics Market, Revenues & Volume, By Type, 2021 - 2031 |
12.4 Middle East Psoriasis Therapeutics Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
13 Global Psoriasis Therapeutics Market Key Performance Indicators |
14 Global Psoriasis Therapeutics Market - Export/Import By Countries Assessment |
15 Global Psoriasis Therapeutics Market - Opportunity Assessment |
15.1 Global Psoriasis Therapeutics Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Psoriasis Therapeutics Market Opportunity Assessment, By Type, 2021 & 2031F |
15.3 Global Psoriasis Therapeutics Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
16 Global Psoriasis Therapeutics Market - Competitive Landscape |
16.1 Global Psoriasis Therapeutics Market Revenue Share, By Companies, 2024 |
16.2 Global Psoriasis Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |